Reach the highest step in sensitivity

INNO-LiPA CFTR is a multiparameter line probe assay, based on the reverse hybridization principle, for the simultaneous detection and identification of 8 large rearrangements and 6 mutations and their wild-type sequences in human whole blood, dried blood spots, and buccal brush samples.

For the detection and identification of all ACMG mutations the INNO-LiPA CFTR 19 and INNO-LiPA CFTR 17+Tn Update kits are both required to be tested (testing for 35 mutations, one polymorphism and three Tn variants).

Well-defined study cohorts prove that large rearrangements in the CFTR gene account for 16-26% of unidentified CF alleles in various populations.

Large rearrangements, of which large deletions are the most common type, have a high clinical relevance as they will always lead to a severe form of the disease in presence of another CF causing mutation.

This strip contains mutations that have a significant frequency in Italy, Bulgaria, Turkey and Hispanic Countries.

Features & Benefits

• The combination of the 2 strips, CFTR 19 and CFTR 17 + Tn Update covers the panel of CFTR mutations recommended by the ACMG/ACOG (23 mutations). The combination of these two strips can be tested in one trough. 
• The CFTR Deletions + 6 strip:
  • Detects the 8 most frequent large CFTR Deletions 
  • Detection of six (6) additional severe disease-causing mutations including the second most frequent mutation in the Turkish population (1677delTA) 
  • Provides an increased overall detection rate of up to 3.5% 
  • Only one amplification is needed 
• One test procedure for the complete INNO-LiPA CFTR portfolio. 
• Both INNO-LiPA CFTR Deletions + 6 and INNO-LiPA CFTR Italian Regional can be tested in the same strip trough. 
• The test is fast and easy to perform, offers quick visual interpretation, and full results are obtained within one working day. 
• Fully automated processing of the strips is possible using TENDIGO™, Auto-LiPA™ 48 and AutoBlot 3000H and interpretation via the LiRAS for LiPA Cystic Fibrosis Software.
• Objective manual processing and interpretation also available.

For more information, visit Fujirebio.com.